Jasgit C. Sachdev
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
Papers in
- Oncology 21
- Cancer Immunotherapy and Biomarkers 8
- PARP inhibition in cancer therapy 5
- Cancer Treatment and Pharmacology 3
-
- Breast Cancer Treatment Studies 6
- Co-authors
- Mitesh J. Borad (2 shared papers)Jay Stoudemire (2 shared papers)Andreas G. Bader (2 shared papers)Muhammad S. Beg (1 shared paper)Andrew Jacob Brenner (1 shared paper)Sinil Kim (1 shared paper)Yoon‐Koo Kang (1 shared paper)David S. Hong (1 shared paper)
- Journals
- Annals of Oncology (9 papers)Clinical Cancer Research (8 papers)European Journal of Cancer (6 papers)Gynecologic Oncology (4 papers)British Journal of Cancer (3 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Jasgit C. Sachdev
59 papers receiving 6.5k citations
Jasgit C. Sachdev's Hit Papers
Peers
Comparison fields: 5 of 116
- Cancer Research 1.4k
- Oncology 1.6k
- Hepatology 407
- Biomaterials 414
- Reproductive Medicine 248
Countries citing papers authored by Jasgit C. Sachdev
This map shows the geographic impact of Jasgit C. Sachdev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasgit C. Sachdev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasgit C. Sachdev more than expected).
Fields of papers citing papers by Jasgit C. Sachdev
This network shows the impact of papers produced by Jasgit C. Sachdev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasgit C. Sachdev. The network helps show where Jasgit C. Sachdev may publish in the future.
Co-authors
The 25 scholars most cited alongside Jasgit C. Sachdev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hepatobiliary Cancers Hit paper breakdown → | 2009 | 1987 |
| 2 | Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours Hit paper breakdown → | 2020 | 770 |
| 3 | Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors Hit paper breakdown → | 2016 | 751 |
| 4 | Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma Hit paper breakdown → | 2019 | 469 |
| 5 | 2017 | 343 | |
| 6 | 2018 | 301 | |
| 7 | 2016 | 247 | |
| 8 | 2016 | 222 | |
| 9 | 2016 | 209 | |
| 10 | 2017 | 155 | |
| 11 | 2019 | 135 | |
| 12 | 2011 | 129 | |
| 13 | 2017 | 89 | |
| 14 | 2021 | 73 | |
| 15 | 2020 | 72 | |
| 16 | 2014 | 71 | |
| 17 | 2020 | 61 | |
| 18 | 2015 | 56 | |
| 19 | 2020 | 42 | |
| 20 | 2020 | 33 |
About Jasgit C. Sachdev
Jasgit C. Sachdev is a scholar working on Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Biomaterials, having authored 60 papers that have together received 6.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Breast Cancer Treatment Studies (6 papers), Lung Cancer Treatments and Mutations (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), PARP inhibition in cancer therapy (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (1.6k citations), Hepatology (407 citations), Biomaterials (414 citations) and Reproductive Medicine (248 citations). Jasgit C. Sachdev has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Mitesh J. Borad, Jay Stoudemire, Andreas G. Bader, Muhammad S. Beg, Andrew Jacob Brenner, Sinil Kim, Yoon‐Koo Kang, David S. Hong, Ramesh K. Ramanathan and Carolyn Kay McCourt. Their work appears in journals such as Annals of Oncology, Clinical Cancer Research, European Journal of Cancer, Gynecologic Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.